Rethinking Reanalysis

被引:26
作者
Christakis, Dimitri A. [1 ]
Zimmerman, Frederick J. [2 ]
机构
[1] Seattle Childrens Res Inst, Seattle, WA USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2013年 / 310卷 / 23期
关键词
BONE MORPHOGENETIC PROTEIN-2; METAANALYSIS; FUSION;
D O I
10.1001/jama.2013.281337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2499 / 2500
页数:2
相关论文
共 9 条
  • [1] [Anonymous], 2013, WALL STR J
  • [2] The Diesel Exhaust in Miners Study: A Cohort Mortality Study With Emphasis on Lung Cancer
    Attfield, Michael D.
    Schleiff, Patricia L.
    Lubin, Jay H.
    Blair, Aaron
    Stewart, Patricia A.
    Vermeulen, Roel
    Coble, Joseph B.
    Silverman, Debra T.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (11): : 869 - 883
  • [3] Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Spine Fusion A Systematic Review and Meta-analysis
    Fu, Rongwei
    Selph, Shelley
    McDonagh, Marian
    Peterson, Kimberly
    Tiwari, Arpita
    Chou, Roger
    Helfand, Mark
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 158 (12) : 890 - +
  • [4] A Model for Dissemination and Independent Analysis of Industry Data
    Krumholz, Harlan M.
    Ross, Joseph S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (14): : 1593 - 1594
  • [5] Meier B., 2011, NY TIMES, pB5
  • [6] National Institutes of Health, FIN NIH STAT SHAR RE
  • [7] Attacks on science: The risks to evidence-based policy
    Rosenstock, L
    Lee, LJ
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2002, 92 (01) : 14 - 18
  • [8] Rowland Christopher, 2013, BOSTON GLOBE
  • [9] Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion A Meta-analysis of Individual-Participant Data
    Simmonds, Mark C.
    Brown, Jennifer V. E.
    Heirs, Morag K.
    Higgins, Julian P. T.
    Mannion, Richard J.
    Rodgers, Mark A.
    Stewart, Lesley A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 158 (12) : 877 - +